Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

21.00

+0.89

(+4.43%)

At close: 04:00PM EDT

20.90

-0.10

(-0.48%)

After hours:

04:16PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Price Crosses Moving Average

View all chart patterns

Performance Outlook

Previous Close	20.25
Open	20.41
Bid	17.47 x 800
Ask	20.90 x 1100
Day's Range	19.90 - 21.00
52 Week Range	15.83 - 25.68
Volume	578,358
Avg. Volume	975,309

Market Cap	2.424B
Beta (5Y Monthly)	0.54
PE Ratio (TTM)	22.98
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

-7% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for CORT

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Corcept Therapeutics Incorporat
CORT: Raising target price to $21.00CORCEPT THERAPEUTICS INC has an Investment Rating of BUY; a target price of $21.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of High; and a Value Subrating of Medium.
Rating
Fair Value
Economic Moat
9 days agoArgus Research